← Back to Search

Behavioral Intervention

PVSET for Emotional Well-Being in Police and Military Personnel

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have no current psychosis, untreated bipolar disorder, or current suicidal ideation with plan and intent
Have previously participated in at least one evidence-based psychological treatment for depressive, anxiety, or trauma-and-stressor-related condition at OSIC but remain clinically symptomatic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial will study if a treatment can reduce anxiety, trauma and depression symptoms, improve positive emotions, functioning and quality of life in CAF/RCMP members.

Who is the study for?
This trial is for active or veteran members of the Canadian Armed Forces and Royal Canadian Mounted Police who still have symptoms after a psychological treatment. They must not be suicidal, experiencing psychosis, or have untreated bipolar disorder. Participants should keep their medication stable during the study and must speak English.Check my eligibility
What is being tested?
The study tests PVSET, a treatment aimed at reducing anhedonia (inability to feel pleasure) and boosting positive emotions in police and military personnel. It evaluates changes in anxiety, trauma, depression symptoms, emotional well-being, overall functioning, and life quality.See study design
What are the potential side effects?
While specific side effects are not listed for PVSET as it's likely a form of therapy rather than medication, participants may experience discomfort discussing personal experiences or temporary increases in distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have untreated bipolar disorder, psychosis, or current thoughts of suicide with a plan.
Select...
I've had psychological treatment for depression, anxiety, or trauma at OSIC but still have symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PTSD symptoms
Change in anxiety symptoms
Change in depression symptoms
Secondary outcome measures
Change in positive and negative affect
Change in quality of life
Psychotherapy progress
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PVSETExperimental Treatment1 Intervention
Participants will receive a course of individual therapy through the Operational Stress Injury Clinic (OSIC) at Deer Lodge Centre. Therapy will consist of a validated treatment protocol known as Positive Valence System Enhancement Treatment for Anxiety and Depression (PVSET), which will consist of psychoeducation and positive activity interventions designed to increase positive emotions, cognitions, and behaviors. Therapy sessions will be facilitated by psychologists, licensed therapists (e.g., MSW, RPN), and/or graduate students in psychology under supervision at the OSIC. PVSET will consist of 6 sessions, each lasting one hour, and will be delivered either virtually or in-person at OSIC depending on patient preference.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,416 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a recruitment drive underway for this trial at the moment?

"Unfortunately, the clinical trial data available on clinicialtrials.gov confirms that this study is not currently recruiting patients. Originally posted on September 5th 2023 and last updated a day later, there are fortunately 34 other trials actively enrolling participants at present."

Answered by AI

What is the goal of this research endeavor?

"The primary evaluation parameter of this 6-week clinical trial is the Change in PTSD symptoms, with secondary metrics being a percentage score on Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-SF), Psychotherapy progress as measured by Outcome Questionnaire 45 (OQ45) results, and Treatment acceptability based on responses to the corresponding questionnaire."

Answered by AI
~41 spots leftby Apr 2025